1. Home
  2. CRTO vs PTGX Comparison

CRTO vs PTGX Comparison

Compare CRTO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$16.30

Market Cap

818.3M

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$142.25

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRTO
PTGX
Founded
2005
2006
Country
France
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
818.3M
9.3B
IPO Year
2013
2016

Fundamental Metrics

Financial Performance
Metric
CRTO
PTGX
Price
$16.30
$142.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
13
Target Price
$34.00
★ $108.23
AVG Volume (30 Days)
190.5K
★ 526.9K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.95
N/A
EPS
0.37
★ 2.35
Revenue
★ $2,296,692,000.00
N/A
Revenue This Year
N/A
$874.25
Revenue Next Year
$5.54
N/A
P/E Ratio
★ $44.76
$58.44
Revenue Growth
★ 27.65
N/A
52 Week Low
$15.58
$62.24
52 Week High
$25.29
$160.81

Technical Indicators

Market Signals
Indicator
CRTO
PTGX
Relative Strength Index (RSI) 33.95 46.76
Support Level $15.58 $141.95
Resistance Level $19.85 $151.24
Average True Range (ATR) 0.45 5.11
MACD -0.02 -0.89
Stochastic Oscillator 4.70 48.37

Price Performance

Historical Comparison
CRTO
PTGX

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: